Clinical Trial Update: LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for LEO 80185 Gel (calcipotriol hydrate plus betamethasone dipropionate) in Japanese subjects with psoriasis vulgaris; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• LEO 80185 Gel

Snippet

Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2021-07-27